Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression
L -Ascorbic acid (vitamin C, AA) exhibits anti-cancer effects with high-dose treatment through the generation of reactive oxygen species (ROS) and selective damage to cancer cells. The anti-cancer effects of L -ascorbic acid are determined by sodium-dependent vitamin C transporter 2 (SVCT-2), a tran...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2018-07, Vol.8 (1), p.11372-9, Article 11372 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | L
-Ascorbic acid (vitamin C, AA) exhibits anti-cancer effects with high-dose treatment through the generation of reactive oxygen species (ROS) and selective damage to cancer cells. The anti-cancer effects of
L
-ascorbic acid are determined by sodium-dependent vitamin C transporter 2 (SVCT-2), a transporter of
L
-ascorbic acid. In this study, we demonstrate that
L
-ascorbic acid treatment showed efficient anti-cancer activity in cell lines with high expression levels of SVCT-2 for a gradient concentration of
L
-ascorbic acid from 10 μM −2 mM. However, in low SVCT-2 expressing cell lines, high-dose
L
-ascorbic acid (>1 mM) showed anti-cancer effects but low-dose ( |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-018-29386-7 |